Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

L-Citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats.

Authors: Vadivel, A  Aschner, JL  Rey-Parra, GJ  Magarik, J  Zeng, H  Summar, M  Eaton, F  Thebaud, B 
Citation: Vadivel A, etal., Pediatr Res. 2010 Aug 27.
Pubmed: (View Article at PubMed) PMID:20805789
DOI: Full-text: DOI:10.1203/PDR.0b013e3181f90278

Bronchopulmonary dysplasia (BPD) is characterized by arrested alveolar development and complicated by pulmonary hypertension (PH). Nitric oxide (NO) promotes alveolar growth. Inhaled NO (iNO) ameliorates the BPD phenotype in experimental models and in some premature infants. Arginosuccinate synthetase (ASS) and arginosuccinate lyase (ASL) convert L-citrulline to L-arginine; L-citrulline is regenerated during NO synthesis from L-arginine. Plasma levels of these NO precursors are low in PH. We hypothesized that L-citrulline prevents experimental O2-induced BPD in newborn rats. Rat pups were assigned from birth through postnatal day 14 (P14) to room air (RA), RA+L-citrulline, 95% hyperoxia (BPD model), and 95%O2+L-citrulline. Rat pups exposed to hyperoxia had fewer and enlarged air spaces and decreased capillary density, mimicking human BPD. This was associated with decreased plasma L-arginine and L-citrulline concentrations on P7. L-Citrulline treatment significantly increased plasma L-arginine and L-citrulline concentrations and increased ASL protein expression in hyperoxia. L-Citrulline preserved alveolar and vascular growth in O2-exposed pups and decreased pulmonary arterial medial wall thickness and right ventricular hypertrophy. Increased lung arginase activity in O2-exposed pups was reversed by L-citrulline treatment. L-Citrulline supplementation prevents hyperoxia-induced lung injury and PH in newborn rats. L-citrulline may represent a novel therapeutic alternative to iNO for prevention of BPD. ABBREVIATIONS::

Annotation

Disease Annotations
Objects Annotated

Additional Information

 
RGD Object Information
RGD ID: 4142785
Created: 2010-09-08
Species: All species
Last Modified: 2010-09-08
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.